Epilepsy Advocacy Webinar: Cannabis, Cannabidiol (CBD), Hemp and the 2018 Farm Bill

Update

Originally published on January 2, 2019. 

Webinar on Wednesday, January 9, 2019, at 8:00 p.m. ET

Did you hear about the 2018 Farm Bill recently signed into law? This law affects the legality of certain cannabidiol (CBD) products made from hemp. While more CBD products may come to market in the coming months, it is important to understand that not every CBD product is the same quality or uniform from batch to batch. Any drug or supplement that is being considered for use as a medical treatment should first be discussed with your doctor.

Currently, there is only one FDA-approved cannabidiol (CBD) medicine, Epidiolex^®, indicated for use to treat seizures associated with two rare forms of epilepsy (Lennox-Gastaut syndrome (LGS) and Dravet syndrome).

Join us for an educational webinar:

• “Advocacy Update: Cannabis, Cannabidiol (CBD), Hemp and the 2018 Farm Bill”
• Date: Wednesday, January 9, 2019
• Time: 8:00 to 9:00 p.m. ET

Moderated by Dr. Elaine Kiriakopoulos, director of health communications and engagement for the Epilepsy Foundation, our speakers will discuss,

• The 2018 Farm Bill
• Federal and state legal implications
• What does this mean for people with epilepsy?
• Speaking with your physician and getting the best advice on treating your epilepsy

Guest Speakers

Laura Weidner
Vice President of Government Relations and Advocacy
Epilepsy Foundation

Abbey Roudebush, Esq.
Government Relations Manager
Epilepsy Foundation

Note: presenters cannot address individual medical concerns and cannot provide individual medical or legal advice.